123
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Effects of Twice-daily Topical Difluprednate 0.05% Emulsion in a Child with Pars Planitis

, MD, , MD & , MD
Pages 84-85 | Received 15 Jun 2010, Accepted 30 Jul 2010, Published online: 31 Oct 2010
 

Abstract

Purpose: To report the effects of twice-daily difluprednate in a child with pars planitis (PP).

Design/methods: Case report.

Results: PP was controlled with topical difluprednate for 1 year. Then an atypical pattern of steroid response—delayed, relatively sudden onset of recalcitrant ocular hypertension (OHT)—and posterior subcapsular cataract (PSC) formation necessitated alternative treatment.

Conclusion: Although not a standard treatment, in select cases of PP topical difluprednate therapy could be a useful short-term treatment option while alternative treatments are considered or immunosuppressive agents build to therapeutic levels. Ophthalmologists must be aware of the potential for delayed onset of serious complications when using difluprednate.

ACKNOWLEDGMENTS

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 815.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.